Search Within

Lora Hedrick Ellenson

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (37)
  2. Meeting Abstract (19)
Groups
  1. Department of Pathology and Laboratory Medicine (56)
  2. GDMT, Pathology and Laboratory Medicine (56)
  3. Gynecology Disease Management Team (56)
  4. Sloan Kettering Institute Postdocs (56)
  5. GDMT, Surgery (51)
  6. Surgery (51)

More Groups

People
  1. Nadeem Abu-Rustum (49)
  2. Britta Weigelt (47)
  3. Carol Aghajanian (30)
  4. Jennifer Mueller (26)
  5. Eric Rios-Doria (22)
  6. Mario Leitao (22)

More People

Years
  1. 2025 (5)
  2. 2024 (16)
  3. 2023 (13)
  4. 2022 (16)
  5. 2021 (4)
  6. 2020 (2)
Publications
  1. Gynecologic Oncology (24)
  2. International Journal of Gynecological Cancer (11)
  3. Modern Pathology (6)
  4. Clinical Cancer Research (3)
  5. Cancer (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. Elsevier Inc. (24)
  2. Lippincott Williams & Wilkins (11)
  3. Nature Research (7)
  4. American Association for Cancer Research (5)
  5. Nature Publishing Group (2)
  6. Wiley Blackwell (2)

More Publishers

Results (56)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular subtypes and genomic landscape of undifferentiated and dedifferentiated endometrial cancer
    Journal Article

    Dagher, C.; Selenica, P.; Momeni-Boroujeni, A.; Ellenson, L. H.; Mueller, J. J.; Abu-Rustum, N. R.; Chui, M. H.; Weigelt, B.
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • TROP2 expression and therapeutic targeting in uterine carcinosarcoma
    Journal Article

    Moufarrij, S.; Dopeso, H.; Brown, D. N.; Green, H.; Gill, K.; Tengelin, J.; Brodeur, M. N.; Zammarrelli, W. A. 3rd; Varice, N.; Wu, M.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • ERBB2 amplification occurs late in the pathogenesis of high-grade endometrial carcinomas with HER2 expression heterogeneity
    Meeting Abstract

    Chui, M. H.; Brown, D.; Ellenson, L.; Weigelt, B.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Effect of substantial lymphovascular space invasion on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma
    Journal Article

    Dagher, C.; Bjerre Trent, P.; Alwaqfi, R.; Davidson, B.; Ellenson, L. H.; Zhou, Q.; Iasonos, A.; Mueller, J. J.; Alektiar, K.; Makker, V.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • The genomic landscape of distant metastatic endometrial cancer
    Journal Article

    Zammarrelli, W. A. 3rd; Nandakumar, S.; Kertowidjojo, E.; Nguyen, B.; Moukarzel, L. A.; Da Cruz Paula, A.; Rios-Doria, E. V.; Smith, S. A.; Momeni-Boroujeni, A.; Makker, V.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Patterns of recurrence and prognostic factors in endometrial cancer molecular subtypes
    Meeting Abstract

    Lam, C.; Dagher, C.; Ellenson, L. H.; Mueller, J. J.; Weigelt, B.; Abu-Rustum, N.; Momeni-Boroujeni, A.
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • TROP2 as a novel target in uterine carcinosarcoma organoid models
    Meeting Abstract

    Moufarrij, S.; Dopeso, H.; Green, H.; Gill, K.; Brown, D.; Zammarrelli, W.; Varice, N.; Wu, M.; Paula, A. D.; de Oliveira, T. B.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Whole-genome sequencing-based genomic characterization of uterine serous carcinoma
    Meeting Abstract

    Andres, S.; Brown, D.; Da Cruz Paula, A.; Aghajanian, C.; Abu-Rustum, N.; Ellenson, L.; Weigelt, B.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Concurrent POLE hotspot mutations and mismatch repair deficiency in endometrial cancer: Defining cancer drivers
    Meeting Abstract

    Moufarrij, S.; Gazzo, A.; Selenica, P.; Abu-Rustum, N.; Ellenson, L.; Liu, Y.; Weigelt, B.; Momeni-Boroujeni, A.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Sensitivity of HER2-low uterine carcinosarcoma organoids to the antibody-drug conjugate, trastuzumab deruxtecan
    Meeting Abstract

    Moufarrij, S.; Dopeso, H.; Green, H.; Gill, K.; Brown, D.; Zammarrelli, W.; Varice, N.; Wu, M.; Paula, A. D.; de Oliveira, T. B.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save